Get started
Author

Guilherme Mendes Sapinho

Case report: VEXAS syndrome: an atypical indolent presentation as sacroiliitis with molecular response to azacitidine
2024 · Roberto Pereira da Costa, Guilherme Sapinho, et al. · Frontiers in Immunology · 15
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study
2025 · Carmelo Gurnari, Hideki Makishima, et al. · Leukemia · 14
Full-Dose Azacitidine in 5 Days Versus 7 Days With a Weekend Break in Myelodysplastic Syndromes: A Retrospective Cohort Study
2023 · Guilherme Sapinho, Lídia Alves-Ribeiro, et al. · Clinical Lymphoma Myeloma & Leukemia · 5
Total Knockdown of LMW-PTP in MDA-MB-231 Cells Reduces Osteoclastogenesis
2017 · GUILHERME SAPINHO, IRINA ALHO, et al. · Anticancer Research · 3
PDF
Improved real‐world outcomes of patients with acute promyelocytic leukaemia treated with first‐line arsenic trioxide in specialized centres in Portugal through a 24/7 phone‐based referral
2026 · Joana Brioso Infante, Eliana Aguiar, et al. · British Journal of Haematology · 1
PDF
Improved Real-World Outcomes of Patients with Acute Promyelocytic Leukemia Treated with First-Line Arsenic Trioxide in Specialized Centers in Portugal through a 24/7 Phone-Based Referral: A Study from the Portuguese Acute Leukemia Group
2024 · Joana Brioso Infante, Eliana Aguiar, et al. · Blood · 1
PDF
A Dedicated System Accounting for Specific Germline/Somatic Genomic Constellations Is Essential to Predict Outcomes in DDX41-Mutant Myeloid Neoplasia
2024 · Carmelo Gurnari, Hideki Makishima, et al. · Blood · 1
PDF
Impact of Somatic Second Hit and Comutations in Myeloid Neoplasms with Germline DDX41 Mutations
2023 · Guilherme Mendes Sapinho, Pramila Krishnamurthy, et al. · Blood · 1
Outcome Prediction in DDX41-Mutant Myelodysplastic Syndromes Is Not Possible with General Disease Schemes and Requires a Dedicated Risk Scoring System
2023 · Carmelo Gurnari, Hideki Makishima, et al. · Blood · 1
Venovenous Extracorporeal Membrane Oxygenation (VV-ECMO) Support in Anaplastic Lymphoma Kinase (ALK)-Positive Anaplastic Large Cell Lymphoma With Pulmonary Involvement at Presentation
2026 · Rui F Gomes, Marta M Sousa, et al. · Cureus
DDX41-related myeloid neoplasms: Insights and treatment landscape in 250 patients managed at a large tertiary centre
2025 · Francesco Versino, Shreyas Hanmantgad, et al. · Blood
PDF
#6719 Acute Kidney Injury and Multiple Myeloma-the Role Cytogenetics: a Cohort Study
2023 · Natacha Rodrigues, Carolina Branco, et al. · Nephrology Dialysis Transplantation
PDF
MDS-308 Impact of Two Azacitidine Administration Schedules in Myelodysplastic Syndromes
2022 · Guilherme Sapinho, Lídia Alves-Ribeiro, et al. · Clinical Lymphoma Myeloma & Leukemia
Poster: MDS-308 Impact of Two Azacitidine Administration Schedules in Myelodysplastic Syndromes
2022 · Guilherme Sapinho, Lídia Alves-Ribeiro, et al. · Clinical Lymphoma Myeloma & Leukemia
Differential role of low molecular weight protein tyrosine phosphatase (total and slow isoform) in bone metastases from breast cancer
2016 · Guilherme Sapinho · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Works count: 15
Citation count: 42
H-index: 3
I10-index: 2
Year
Topic
Type